The AAA + ATPase Thorase is neuroprotective against ischemic injury.
Jianmin ZhangJia YangHuaishan WangOmar SherbiniMatthew J KeussGeorge Ke UmanahEmily Ling-Lin PaiZhikai ChiKaisa Ma PaldaniusWei HeHong WangShaida A AndrabiTed M DawsonValina L DawsonPublished in: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2018)
Neuronal preconditioning in vitro or in vivo with a stressful but non-lethal stimulus leads to new protein expression that mediates a profound neuroprotection against glutamate excitotoxicity and experimental stroke. The proteins that mediate neuroprotection are relatively unknown and under discovery. Here we find that the expression of the AAA + ATPase Thorase is induced by preconditioning stimulation both in vitro and in vivo. Thorase provides neuroprotection in an ATP-dependent manner against oxygen-glucose deprivation (OGD) neurotoxicity or glutamate N-Methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity in vitro. Knock-down of Thorase prevents the establishment of preconditioning induced neuroprotection against OGD or NMDA neurotoxicity. Transgenic overexpression of Thorase provides neuroprotection in vivo against middle cerebral artery occlusion (MCAO)-induced stroke in mice, while genetic deletion of Thorase results in increased injury in vivo following stroke. These results define Thorase as a neuroprotective protein and understanding Thorase signaling could offer a new therapeutic strategy for the treatment of neurologic disorders.
Keyphrases
- cerebral ischemia
- subarachnoid hemorrhage
- brain injury
- blood brain barrier
- middle cerebral artery
- high glucose
- diabetic rats
- poor prognosis
- atrial fibrillation
- cell proliferation
- type diabetes
- binding protein
- transcription factor
- adipose tissue
- gene expression
- blood glucose
- autism spectrum disorder
- single cell
- insulin resistance
- high fat diet induced